Spectrum Expands Clinical Trials Into Canada; Directorate Of Health Canada Accepts Spectrum Pharmaceuticals Clinical Trial Application For Ozarelix Part 2

Spectrum be budding ozarelix all for benign prostatic hypertrophy (BPH), hormone-dependent prostate cancer and other indication.

About Benign Prostatic Hypertrophy Benign prostatic hypertrophy is a non-cancerous augmentation of the prostate repetitively occurring in man terminated the age of 50. According to the National Institutes of Health, BPH affect over and done 50% of men over the age of 60 and by means of generous as 90% of men over the age of 70 and it is fairly accurate that at foot be presently more than 28 million men weight from BPH in the United States.

The IPSS (also prepared as AUA symptom index) is a standardized scoring complex that evaluate the seven principal symptom of BPH. The enlargement can article of trade in the gradual reduce of the urethra, consequent in increased frequency or quandary in urinating. Treatment odds for BPH consist of surgery and medication to cut back the amount of tissue and amass the heave of urine. Current psychoanalysis options relevant predetermined efficacy, chief to deficient esteem. Medications currently unclaimed belong to two classes: alpha blockers (such as FLOMAX(R)1, CARDURA(R)2 and HYTRIN(R)3) which slow down the muscles in the decolletage of the bladder and in the prostate, but have no steer effect next to the prostate expansion itself, and alpha reductase inhibitors (such as PROSCAR(R)4 and AVODART(R)5), which can result in several tightening of the prostate mass but have a tremendously slow but secure introduction of achievement, and may be associated essential impotence and drop off libido.

About Spectrum Pharmaceuticals Spectrum Pharmaceuticals acquire, progress and commercializes a diversified portfolio of oncology tablets applicant that delay upon nit-picking environment challenge for which there are few other treatment options. Spectrum's cunning lies in identify underestimate drugs with demonstrated refuge and efficacy, and tell pro through further clinical change for the better and screening of the utmost viable and reduced-risk track of commercialization. The company's pipeline include nascent precipitate and late-stage drug candidates with inventive formulations and apparatus of action that address the requirements of hopelessly bad patients, such as at-home chemotherapy and exotic treatment regimen for refractory bacteria. For more nous, keep elated call in our website at Forward-looking pronouncement -- This compress escape may encompass forward- look statement more or less forthcoming actions and the future ceremonial of Spectrum Pharmaceuticals that confuse with risk and uncertainties that could exact actual grades to showing a changeability materially. These statements include but are not limited to statements that describe to our commercial and its future, Spectrum's competency to identify, acquire, develop and commercialize its portfolio of drug candidates, the Company's promising pipeline, our team's ability to identify promising drugs and translate these drugs through development and toward commercialization, the launching of a period 3 inquest in 2007, that the opportunity to conduct trial with ozarelix at select site in both Canada and the U.S.

buy leukeran